IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER
Leukemia
Jonsson Comprehensive Cancer Centermonoclonal_antibodyPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 58/ 100
- Competitive Position
- 65/ 100
Competitive context
125 Active assets in the Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VINCRISTINE SULFATE Inhye Ahn | Phase 3 | BB |
ASPARAGINASE Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 3 | BB |
THIOGUANINE ANHYDROUS Incyte Corporation | Phase 3 | BB |
Idarubicine Affiliated Hospital of Nantong University | Phase 3 | BB |
Daunorubicin Richard Stone, MD | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →